Epidemiology of Aspergillosis in Cancer Patients in Taiwan

Chien-An Chen,1,2,* Chung-Han Ho,3– 5,* Yu-Cih Wu,3 Yi-Chen Chen,3 Jhi-Joung Wang,3 Kuang-Ming Liao6 1Division of Hepatogastroenterology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, 71004, Taiwan; 2Division of Hospital Medicine, Department of Internal Medicine, C...

Full description

Bibliographic Details
Main Authors: Chen CA, Ho CH, Wu YC, Chen YC, Wang JJ, Liao KM
Format: Article
Language:English
Published: Dove Medical Press 2022-07-01
Series:Infection and Drug Resistance
Subjects:
Online Access:https://www.dovepress.com/epidemiology-of-aspergillosis-in-cancer-patients-in-taiwan-peer-reviewed-fulltext-article-IDR
_version_ 1811224951959584768
author Chen CA
Ho CH
Wu YC
Chen YC
Wang JJ
Liao KM
author_facet Chen CA
Ho CH
Wu YC
Chen YC
Wang JJ
Liao KM
author_sort Chen CA
collection DOAJ
description Chien-An Chen,1,2,&ast; Chung-Han Ho,3– 5,&ast; Yu-Cih Wu,3 Yi-Chen Chen,3 Jhi-Joung Wang,3 Kuang-Ming Liao6 1Division of Hepatogastroenterology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, 71004, Taiwan; 2Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, 71004, Taiwan; 3Department of Medical Research, Chi Mei Medical Center, Tainan, 71004, Taiwan; 4Department of Information Management, Southern Taiwan University of Science and Technology, Tainan, 71005, Taiwan; 5Cancer Center, Taipei Municipal Wanfang Hospital, Taipei Medical University, Taipei, 11696, Taiwan; 6Department of Internal Medicine, Chi Mei Medical Center, Chiali, Tainan, 72263, Taiwan&ast;These authors contributed equally to this workCorrespondence: Kuang-Ming Liao, Department of Internal Medicine, Chi Mei Medical Center, Chiali, Tainan, 72263, Taiwan, Tel +886 6 726 3333, Email abc8870@yahoo.com.twPurpose: The incidence of aspergillosis is increasing, and the risk factors for infection include cancer, admission to the intensive care unit, chronic pulmonary diseases, immunocompromised status, and taking immunomodulatory drugs. There are limited data about the incidence of aspergillosis in patients with different types of cancer. The aim of our study was to survey the incidence of aspergillosis in different cancer types from 2006 to 2017.Patients and Methods: Data were collected from the Taiwan Cancer Registry database and International Classification of Diseases, 9th, 10th Revision, and Clinical Modification codes for diagnosing aspergillosis. Patients with a history of aspergillosis before cancer were excluded, and the secondary outcome was the risk of mortality in cancer patients with and without aspergillosis after 1 year.Results: Among 951 cancer patients with a diagnosis of aspergillosis, there were 614 hematopoietic and reticuloendothelial system patients, 100 lung cancer patients, and 73 lymphoma cancer patients. The overall incidence rates of aspergillosis tended to increase significantly from 2006 to 2017 (from 3.50 to 13.37 per 10,000 person-years, p value: < 0.0001). Regarding sex, the incidence rates of aspergillosis in males and females were 12.52 and 7.53 per 10,000 person-years, respectively. Patients with a diagnosis of aspergillosis had a 2.30-fold (95% CI: 2.14– 2.48, p value: < 0.0001) higher risk of mortality than those without aspergillosis.Conclusion: The incidence of aspergillosis was increased in cancer patients, and cancer patients with aspergillosis had a significantly higher risk of mortality than those without aspergillosis.Keywords: aspergillosis, cancer patients, Taiwan Cancer Registry, incidence rate
first_indexed 2024-04-12T08:57:28Z
format Article
id doaj.art-bb8698bee5da4612af7b033bdaa07274
institution Directory Open Access Journal
issn 1178-6973
language English
last_indexed 2024-04-12T08:57:28Z
publishDate 2022-07-01
publisher Dove Medical Press
record_format Article
series Infection and Drug Resistance
spelling doaj.art-bb8698bee5da4612af7b033bdaa072742022-12-22T03:39:21ZengDove Medical PressInfection and Drug Resistance1178-69732022-07-01Volume 153757376676559Epidemiology of Aspergillosis in Cancer Patients in TaiwanChen CAHo CHWu YCChen YCWang JJLiao KMChien-An Chen,1,2,&ast; Chung-Han Ho,3– 5,&ast; Yu-Cih Wu,3 Yi-Chen Chen,3 Jhi-Joung Wang,3 Kuang-Ming Liao6 1Division of Hepatogastroenterology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, 71004, Taiwan; 2Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, 71004, Taiwan; 3Department of Medical Research, Chi Mei Medical Center, Tainan, 71004, Taiwan; 4Department of Information Management, Southern Taiwan University of Science and Technology, Tainan, 71005, Taiwan; 5Cancer Center, Taipei Municipal Wanfang Hospital, Taipei Medical University, Taipei, 11696, Taiwan; 6Department of Internal Medicine, Chi Mei Medical Center, Chiali, Tainan, 72263, Taiwan&ast;These authors contributed equally to this workCorrespondence: Kuang-Ming Liao, Department of Internal Medicine, Chi Mei Medical Center, Chiali, Tainan, 72263, Taiwan, Tel +886 6 726 3333, Email abc8870@yahoo.com.twPurpose: The incidence of aspergillosis is increasing, and the risk factors for infection include cancer, admission to the intensive care unit, chronic pulmonary diseases, immunocompromised status, and taking immunomodulatory drugs. There are limited data about the incidence of aspergillosis in patients with different types of cancer. The aim of our study was to survey the incidence of aspergillosis in different cancer types from 2006 to 2017.Patients and Methods: Data were collected from the Taiwan Cancer Registry database and International Classification of Diseases, 9th, 10th Revision, and Clinical Modification codes for diagnosing aspergillosis. Patients with a history of aspergillosis before cancer were excluded, and the secondary outcome was the risk of mortality in cancer patients with and without aspergillosis after 1 year.Results: Among 951 cancer patients with a diagnosis of aspergillosis, there were 614 hematopoietic and reticuloendothelial system patients, 100 lung cancer patients, and 73 lymphoma cancer patients. The overall incidence rates of aspergillosis tended to increase significantly from 2006 to 2017 (from 3.50 to 13.37 per 10,000 person-years, p value: < 0.0001). Regarding sex, the incidence rates of aspergillosis in males and females were 12.52 and 7.53 per 10,000 person-years, respectively. Patients with a diagnosis of aspergillosis had a 2.30-fold (95% CI: 2.14– 2.48, p value: < 0.0001) higher risk of mortality than those without aspergillosis.Conclusion: The incidence of aspergillosis was increased in cancer patients, and cancer patients with aspergillosis had a significantly higher risk of mortality than those without aspergillosis.Keywords: aspergillosis, cancer patients, Taiwan Cancer Registry, incidence ratehttps://www.dovepress.com/epidemiology-of-aspergillosis-in-cancer-patients-in-taiwan-peer-reviewed-fulltext-article-IDRaspergillosiscancer patientstaiwan cancer registryincidence rate
spellingShingle Chen CA
Ho CH
Wu YC
Chen YC
Wang JJ
Liao KM
Epidemiology of Aspergillosis in Cancer Patients in Taiwan
Infection and Drug Resistance
aspergillosis
cancer patients
taiwan cancer registry
incidence rate
title Epidemiology of Aspergillosis in Cancer Patients in Taiwan
title_full Epidemiology of Aspergillosis in Cancer Patients in Taiwan
title_fullStr Epidemiology of Aspergillosis in Cancer Patients in Taiwan
title_full_unstemmed Epidemiology of Aspergillosis in Cancer Patients in Taiwan
title_short Epidemiology of Aspergillosis in Cancer Patients in Taiwan
title_sort epidemiology of aspergillosis in cancer patients in taiwan
topic aspergillosis
cancer patients
taiwan cancer registry
incidence rate
url https://www.dovepress.com/epidemiology-of-aspergillosis-in-cancer-patients-in-taiwan-peer-reviewed-fulltext-article-IDR
work_keys_str_mv AT chenca epidemiologyofaspergillosisincancerpatientsintaiwan
AT hoch epidemiologyofaspergillosisincancerpatientsintaiwan
AT wuyc epidemiologyofaspergillosisincancerpatientsintaiwan
AT chenyc epidemiologyofaspergillosisincancerpatientsintaiwan
AT wangjj epidemiologyofaspergillosisincancerpatientsintaiwan
AT liaokm epidemiologyofaspergillosisincancerpatientsintaiwan